Summary & Overview
CPT 57454: Colposcopy with Cervical Biopsy and Endocervical Sampling
CPT code 57454 represents a diagnostic colposcopy with cervical biopsy(s) and endocervical sampling. This procedure enables direct visualization of the cervix and adjacent vaginal tissue using a colposcope and includes targeted biopsy and endocervical tissue collection. Nationally, this code is central to evaluation and management of abnormal cervical screening results and contributes to pathways for detecting precancerous cervical disease.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and operational considerations relevant to billing and coding. The publication summarizes benchmark utilization patterns, common modifier usage, and billing practice considerations where available. It also highlights policy and coverage factors that affect coding and reimbursement for colposcopic examinations with biopsy and endocervical sampling.
The content is intended for clinicians, coding professionals, and policy analysts seeking a clear, national-level overview of CPT code 57454, including clinical purpose, payer coverage scope, and areas where coding practice commonly requires attention. Data not available in the input is identified as such in applicable sections.
Billing Code Overview
CPT code 57454 describes a colposcopic examination of the cervix, including evaluation of the upper or adjacent portion of the vagina with a colposcope, combined with cervical biopsy(s) and collection of tissue from the endocervical canal. The procedure is performed to visually inspect and sample abnormal cervical epithelium when screening or diagnostic evaluation indicates possible precancerous or other significant lesions.
-
Service type: Diagnostic colposcopy with cervical biopsy(s) and endocervical sampling
-
Typical site of service: Outpatient ambulatory surgical center or hospital outpatient department; may also be performed in office-based specialty clinics
Clinical & Coding Specifications
Clinical Context
A 34-year-old woman presents to a gynecology clinic after an abnormal cervical cytology result (high‑grade squamous intraepithelial lesion) on screening Pap test and a positive high‑risk human papillomavirus (HPV) test. The clinician schedules a diagnostic colposcopy with directed cervical biopsies and endocervical curettage to evaluate the transformation zone and to obtain tissue for histopathology.
The patient arrives to an outpatient gynecology clinic or ambulatory surgical center. After informed consent and positioning in stirrups, the provider performs a speculum exam and visualizes the cervix. A colposcope is used to magnify and illuminate the cervix and upper vagina. Acetic acid and/or Lugol’s iodine are applied to highlight abnormal epithelium. The provider documents colposcopic findings, takes directed punch biopsies of suspicious areas of the cervix, and performs endocervical sampling (endocervical curettage or brush) to sample the endocervical canal. Hemostasis is achieved and post‑procedure instructions are provided. Specimens are labeled and sent to pathology. Typical sites of service include outpatient gynecology clinics, hospital outpatient departments, and ambulatory surgical centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a Evaluation & Management (E/M) visit is performed and documented as distinct from the colposcopy with biopsy service. |